Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
European Society of Cardiology Congress: Traditional Chinese Medicine Qili Qiangxin significantly reduces the risk of cardiovascular death and re-hospitalization due to heart failure 2023-08-30 20:11
Igniting Innovation, Catalyzing Changes: Bio Farma x MIT Hacking Medicine Hackathon Celebrates Success 2023-08-30 16:16
GC Biopharma to organize "Donate Blood with Love", a healthy way of giving back to the community 2023-08-30 16:05
Asieris Obtained IND Approval from NMPA for APL-1401, a Drug for the Treatment of Moderately-to-Severely Active Ulcerative Colitis 2023-08-30 14:19
InxMed Receives Approval to Initiate Phase I Clinical Trial in China for OMTX705, a First-in-Class FAP-Targeting ADC 2023-08-30 11:00
Fosun Pharma Announces 2023 Interim Results: Continues to Promote Innovation Transformation and Optimizes Product Structure 2023-08-30 10:53
Akeso Announced 2023 Interim Results: First Profit, Growing Sales of PD-1/CTLA-4 Bispecific Antibody and Priority Review of PD-1/VEGF 2023-08-30 08:03
Cerecin to Present New Infantile Spasms Data at the 35th International Epilepsy Congress, Dublin 2023 2023-08-30 00:04
Cerecin to Present New Infantile Spasms Data at the 35th International Epilepsy Congress, Dublin 2023 2023-08-30 00:02
Viva Biotech (1873.HK) Announces 2023 Interim Results：Solid Growth in Main Business, Significant Rebound in Profitability 2023-08-29 22:38
Akeso Announced Completion of Patient Enrollment in Phase 3 Trial of Ivonescimab (PD-1/VEGF) versus Pembrolizumab in First-line PD-L1 Positive Advanced NSCLC 2023-08-29 20:00
Bayer Launches Stunting Prevention Program "CETING" for Community of Cisalak, Depok 2023-08-29 13:53
ProfoundBio to Participate in the 21st Annual Morgan Stanley Conference 2023-08-28 20:00
Ferinject® granted upgraded recommendations in 2023 ESC heart failure guidelines 2023-08-28 19:00
Harbour BioMed Announces 2023 Interim Results 2023-08-28 17:08
Harbour BioMed Announces US IND Clearance of Its First ADC Program HBM9033 in Solid Tumors 2023-08-28 16:30
Jiangsu Recbio Technology Co., Ltd. announced 2023 interim results report and latest progress 2023-08-28 11:08
Specialised Therapeutics acquires commercialisation rights to new oral MND therapy 2023-08-28 04:00
First participant treated at the highest dose level in Clarity's theranostic prostate cancer trial 2023-08-25 20:58
Akeso Announced that Ivonescimab Granted Priority Review of NDA by China NMPA 2023-08-25 20:00
1 44 45 46 47 48 374